(ZYBT - ZHENGYE BIOTECHNOLOGY HOLDING LTD)

company profile

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Zhengye Biotechnology Holding (ZYBT) is trading at 0.8404

Open Price
0.78
Previous close
0.8404
Previous close
0.8404
P/E Ratio
22.1021
Sector
Health Care
Shares outstanding
47391376
Primary exchange
NASDAQ-NMS
ISIN
KYG989MS1016